Get With The Guidelines-Heart Failure Registry

Last updated: January 27, 2025
Sponsor: American Heart Association
Overall Status: Active - Recruiting

Phase

N/A

Condition

Congestive Heart Failure

Chest Pain

Heart Failure

Treatment

GWTG Heart Failure program

Clinical Study ID

NCT02693509
GWTG01
  • Ages 18-125
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Get With The Guidelines-Heart Failure is designed to improve the quality of care in patients hospitalized with heart failure. The program aims to help ensure that eligible patients are initiated on guideline recommended therapies and receive appropriate counseling prior to hospital discharge.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients hospitalized with congestive heart failure.

Exclusion

Exclusion Criteria:

  • Patients who do not have congestive heart failure,

  • Patients under age of 18,

  • Patients not admitted as inpatients.

Study Design

Total Participants: 128026
Treatment Group(s): 1
Primary Treatment: GWTG Heart Failure program
Phase:
Study Start date:
January 01, 2005
Estimated Completion Date:
January 31, 2040

Study Description

Get With The Guidelines-Heart Failure was initiated in 2005 with over 500 U.S. hospitals participating is designed to improve the quality of care in patients hospitalized with heart failure. The program aims to help ensure that eligible patients are initiated on guideline recommended therapies and receive appropriate counseling prior to hospital discharge.

Peer-reviewed research(with over 35 manuscripts) has demonstrated that through participating in Get With The Guidelines-Heart Failure, hospitals will provide equitable care (regardless of race, ethnicity, age, or gender), the importance of scheduled physician follow-up after heart failure hospital discharge, the value in device-support as necessary for the acute heart failure patient, and many other significant findings.

Achievement measures tracked through Get With The Guidelines-Heart Failure:

  • Angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) at discharge

  • Evidence-based specific beta blockers

  • Measure left ventricular function

  • Post-discharge appointment for heart failure patients

Quality Measures tracked through Get With The Guidelines-Heart Failure:

  • Mineralocorticoid receptor antagonist at discharge

  • Aldosterone antagonist at discharge

  • Anticoagulation for atrial fibrillation

  • Hydralazine nitrate at discharge

  • DVT prophylaxis

  • CRT-D or CRT-P placed or prescribed at discharge

  • ICD counseling, or ICD placed or prescribed at discharge

  • Influenza vaccination during flu season

  • Pneumococcal vaccination

  • Follow-up visit within 7 days or less

  • Lab monitoring follow-up

  • SGLT-2 inhibitor at discharge

  • Defect-free care for quadruple therapy medication for patients with heart failure with reduced ejection fraction

  • Direct-acting oral anticoagulant at discharge for non-valvular atrial fibrillation or atrial flutter patients

Additional measures collected by Get With The Guidelines-Heart Failure can be viewed at: http://www.heart.org/idc/groups/heart-public/@wcm/@private/@hcm/@gwtg/documents/downloada ble/ucm_310967.pdf

Connect with a study center

  • American Heart Association

    Dallas, Texas 75231
    United States

    Active - Recruiting

  • Amy Bennett

    Dallas, Texas 75231
    United States

    Active - Recruiting

  • Kelly Burlison

    Dallas, Texas 75231
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.